Biovian
Blood & Organ Banks · Finland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Tykistökatu Biovian Oy 6a, Biocity, Turk...Phone Number
+358 405021332Website
www.biovian.comRevenue
$21.1 MillionIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
2
2
3
2
2
About Biovian
Biovian, founded in 2003 and headquartered in Turku, Finland, is a Nordic Bio-CDMO that provides premium GMP services to biotech companies developing innovative gene therapies or biopharmaceuticals.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biovian your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Biovian
Click to see if Biovian had a recent Job posting/layoffs
Product Launch: Get notified when Biovian launches new products
Funding: Get notified immidiatlly once Biovian has new funding data
Check out if Biovian is spiking on competitors!
Check if Biovian has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Biovian recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Biovian, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Biovian as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Biovian is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Biovian is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Biovian.
Biovian Tech Stack
A closer look at the technologies used by Biovian
Most Recent Scoops
Award
Award, Medical Research, Manufacturing Operations
Open Position
Open Position
Event
Events, Research & Development, Bioengineering, Medical Research, Clinical Operations, Operations
Event
Research & Development, Bioengineering, Medical Research, Clinical Operations, Operations
Biovian News & Media
Eurocine Vaccines publishes half-year report for July-December 2020
Eurocine Vaccines AB (“Eurocine Vaccines”) hereby publishes an interim report for the first half year of 2020. Below is a summary of the report. The full report is available on the Euroccine Vaccines website (https://www.eurocine-vaccines.com/) and as an attachment. 2020-07-01– 2020-12-31 (first half year) · Result after tax during the first half year amounted to -7,6 MSEK (-4,7 MSEK) · Revenues during the half year amounted to 0,4 MSEK (0 MSEK) · Earnings per shareEQT Credit provides financing to support the acquisition of Biovian
EQT Credit, through its Mid-Market investment strategy, is pleased to announce that it has provided the financing to support Keensight Capital and ERES’ (the “Shareholders”) investment in Biovian (or the “Company”), a leading European player in contract manufacturing and development of biopharmaceuticals. The Company offers outsourcing services in process development and contract manufacturing for small and medium size biotechnology firms and has deep industry expertise across different key biolKeensight Capital invests in Biovian
Keensight Capital has acquired a majority stake in Biovian, a European specialist in contract manufacturing and development of biopharmaceuticals, alongside the founders and the managers, and Edmond de Rothschild Equity Strategies (ERES) funds.
Read more news
Top Blood & Organ Banks Companies
See more top companies
Frequently Asked Questions Regarding Biovian
Sign Up For FreeTo access detailed company insights
Biovian, founded in 2003 and headquartered in Turku, Finland, is a Nordic Bio-CDMO that provides premium GMP services to biotech companies developing innovative gene therapies or biopharmaceuticals.... Read More
